Relay Therapeutics Q3 EPS $(0.54) Beats $(0.83) Estimate, Sales $25.20M Up From $344.00K YoY
Author: Benzinga Newsdesk | November 02, 2023 04:35pm
Relay Therapeutics (NASDAQ:
RLAY) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.83) by 34.94 percent. This is a 28.95 percent increase over losses of $(0.76) per share from the same period last year. The company reported $25.20 million in sales this quarter. This is a 7.23K percent increase over sales of $344.00 thousand the same period last year.
Posted In: RLAY